Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

3.05
Delayed Data
As of Mar 23
 +0.28 / +10.11%
Today’s Change
1.90
Today|||52-Week Range
4.38
+28.15%
Year-to-Date
5 Cheap Breakout Stocks for Superb Returns
Mar 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close2.77
Today’s open2.78
Day’s range2.76 - 3.07
Volume1,847,786
Average volume (3 months)1,003,746
Market cap$338.7M
Dividend yield--
Data as of 3:59pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)-25.86%
Earnings growth (this year)+25.68%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-29.46%
P/E ratioNM
Price/Sales11.02
Price/Book5.00

Competitors

 Today’s
change
Today’s
% change
BOLDAudentes Therapeutic...-0.04-0.26%
PDLIPDL BioPharma Inc-0.02-0.98%
NVAXNovavax Inc+0.03+2.42%
AGENAgenus Inc+0.05+1.29%
Data as of 3:59pm ET, 03/23/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$20.4M
Annual profit (last year)-$69.2M
Net profit margin-339.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Raul R. Rodriguez
CFO, Executive VP &
Head-Investor Relations
Ryan D. Maynard
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs